Pharma Industry Outlook

Exclusive to DCAT Member Companies

Date/Time: Monday, July 12, 2021 - 10:00 AM to 11:00 AM EDT


On-demand viewing of this program for registrants is now closed. Please contact Mikaela Venice at 1-609-208-1888 ext. 7015 for more information.

1-hr Webinar Featuring

  • Graham Lewis, Vice President, Global Pharma Strategy, IQVIA

Program Highlights

  • Latest market data on Bio/Pharmaceutical industry performance
  • Growth prospects in therapeutic and geographical areas
  • Comprehensive, time-effective analysis invaluable for your decision-making


How has the Bio/Pharmaceutical industry performed thus far in 2021, and what can be expected in the near-term? Graham Lewis, Vice President of Global Pharma Strategy, IQVIA, a business intelligence firm regarded as the gold standard for Bio/Pharmaceutical market intelligence, will provide the latest market data and trends for:

  • Innovator and generic drugs
  • Leading therapeutic sectors: pipelines and commercial products
  • Growth prospects in developed and emerging markets
  • Market implications from the pandemic: now and in the future

DCAT’s Pharma Industry Outlook is the most sought-after resource for Bio/Pharmaceutical market data and analysis providing you and your company a comprehensive, yet easy-to-digest analysis of industry performance crucial for your decision-making.  


Who Should Attend

  • C-suite and senior to mid-level executives of Bio/Pharmaceutical Companies, including those involved in sourcing, procurement, supply management, and manufacturing.
  • C-suite and senior to mid-level executives of CDMOs/CMOs and other suppliers, including those in business development, sales, marketing, and operational functions in support of Bio/Pharmaceutical development and manufacturing.

Pricing and Registration

Online registration for this program is now closed. To register over the phone, please contact Mikaela Venice at 1-609-208-1888 ext. 7015.


Speaker Bios